Hematopoietic Stem Cell Transplant
Hematopoietic stem cells in the blood that may have many other applications to treat more than just cancers of the blood. Our team uses hematopoietic stem cell transplant clinical trials to find faster and more personalized tactics solutions for multiple different kinds of cancers throughout the body.
Protocol ID: 10-CBA
Diseases: Umbilical Cord Blood Transplant
Who Can Participate?: There are no age restrictions.
Lead Researcher: Jeffery Auletta
Protocol ID: NCBP CBUs
Disease: Allogeneic HSCT
Who Can Participate?: Ages 0 to 99
Lead Researcher: Hemalatha Geetharani Rangarajan, MD
Protocol ID: NYMC 581-EBV
Disease: Cellular Therapy
Who can participate?: Patients with Epstein-Barr virus infections post allogeneic HSCT or with primaryIncreasing EBV RT-PCR DNA (by 1 log) after 7 days or persistent quantitative EBV RT-PCR DNA copies after 14 days despite two weeks of appropriate anti-viral therapy and/or progressive clinical symptoms attributable to EBV, including biopsy proven colitis, lymphadenopathy, hepatomegaly, splenomegaly and/or Medical intolerance to anti-viral therapies.
Lead Researcher: Rolla F. Abu-Arja
Protocol ID: CD34 Selection
Disease: HSCT
Who can participate?: 1. AML patients needing HSCT in first CR from MSD, with no post HSCT GvHD prophylaxis or 2. Primary or secondary graft failure after allogenic HSCT 3.Poor graft function after allogeneic HSCT 4. Graft source for allogeneic HSCT
Lead Researcher: Rajinder P.S. Bajwa
Protocol ID: PIDTC 6903
Disease: CGD
Who can participate?: CGD who have or will receive a transplant
Lead Researcher: Hemalatha Geetharani Rangarajan
Protocol ID: HapLeuk17
Disease: HSCT
Who can participate?: < 18 years of age. Patient lacks an HLA matched sibling donor. High resolution HLA and KIR typing.
Lead Researcher: Mark A. Ranalli, MD
Protocol ID: HAdV IR
Disease: HSCT
Who can participate?: Patients from 6 months to 18 years old who receive an allogenic HSCT at NCH.
Lead Researcher: Eunkyung Song
Protocol ID: SUN
Disease: Allogeneic HSCT
Who Can Participate?: Ages 2 to 24.99
Lead Researcher: Hemalatha Geetharani Rangarajan, MD
Protocol ID: Stem Cell Data Collection
Diseases: Allogeneic HSCT and Autologous HSCT
Who Can Participate?: New Diagnosis Relapse/Refractory, ages 0 to 99
Lead Researcher: Jeffery J. Auletta, MD
Protocol ID: ACCL1633
Disease: HCT
Who can participate?: Patient must be ≥ 2 years of age and ≤ 25 years of age at time of enrollment. Patient must have a diagnosis that is managed with an alternative donor allogeneic hematopoietic cell transplant.
Lead Researcher: Mark A. Ranalli
Protocol ID: NMDP/Data Collection
Disease: HSCT
Who can participate?: Any recipient of an unrelated or related donor or autologous HC transplant or any recipient of cellular therapy in a CIBMTR center is eligible to participate in the Research Database
Lead Researcher: Jeffery J. Auletta, MD
Protocol ID: NMDP/Sample Repository
Disease: HSCT
Who can participate?: No specific age requirement
Lead Researcher: Jeffery J. Auletta, MD